Insulet Corp (NASDAQ:PODD)
| 295.31 Delayed Data As of 3:59pm ET |  +2.43 / +0.83%Today’s Change | 181.00 Today|||52-Week Range 320.00 | +0.31% Year-to-Date |
Latest PODD News | Press Releases
| Insulet (PODD) Outpaces Stock Market Gains: What You Should Know Feb 01 / Zacks.com - Paid Partner Content | Insulet (PODD) Stock Sinks As Market Gains: What You Should Know Jan 26 / Zacks.com - Paid Partner Content |
| Boston Scientific (BSX) Lags Q4 Earnings Estimates Feb 01 / Zacks.com - Paid Partner Content | Insulet (PODD) Dips More Than Broader Markets: What You Should Know Jan 25 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 292.88 |
| Today’s open | 290.07 |
| Day’s range | 287.54 - 295.31 |
| Volume | 16,459 |
| Average volume (3 months) | 419,198 |
| Market cap | $19.9B |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +136.38% |
| Earnings growth (this year) | +76.46% |
| Earnings growth (next 5 years) | +47.00% |
| Revenue growth (last year) | +21.49% |
| P/E ratio | 1,230.5 |
| Price/Sales | 16.61 |
| Price/Book | 35.60 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WSTWest Pharmaceutical ... | -9.11 | -3.23% |
| SAUHFStraumann Holding AG | +16.48 | +12.75% |
| ---- | ||
| BAXBaxter International... | -0.33 | -0.70% |
Data as of 4:00pm ET, 02/03/2023
Financials
| Next reporting date | February 24, 2023 |
| EPS forecast (this quarter) | $0.21 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $16.8M |
| Net profit margin | 1.53% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Acton, Massachusetts |
Forecasts
